- Financial Review FY2020
In medical and care service industries, medical workers struggled for COVID-19. We sincerely would like to express deep appreciation for your devoted works on the frontiers against COVID-19.
Sales in FY2020 increased 1.7%. Due to COVID-19, negotiations of renewal contracts were impeded, some deliveries of our products, Healthcare wear and Doctors’ wear to medical institutions delayed, and some contracts were postponed to FY2021. Our new COVID-19 prevention products, which we developed in this term, contributed to total growth.
Gross profit to sales in FY2020 decreased 0.9 point(45.8%). Production cost rose, because to meet sharp increase in demand of new COVID-19 prevention products, we realized quick response by using productive capacity in Japan.
|Net sales||¥17,066 million||＋1.7 %|
|Gross profit to sales||45.8 %||-0.9 point|
|Operating income||¥4,937 million||+0.4 %|
|Net income||¥3,474 million||+0.8 %|
|Total assets||¥44,931 million||+1.5 %|